- Home
- TMDX vs LBTYB Comparison
TMDX vs LBTYB Comparison
Compare TMDX & LBTYB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TMDX | LBTYB |
|---|---|---|
| Founded | 1998 | 2004 |
| Country | United States | Bermuda |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Cable & Other Pay Television Services |
| Sector | Health Care | Telecommunications |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.9B | 3.8B |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | TMDX | LBTYB |
|---|---|---|
| Price | $136.66 | $10.96 |
| Analyst Decision | Buy | |
| Analyst Count | 10 | 0 |
| Target Price | ★ $133.00 | N/A |
| AVG Volume (30 Days) | ★ 835.5K | 1.3K |
| Earning Date | 10-29-2025 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 170.70 | N/A |
| EPS | ★ 2.54 | N/A |
| Revenue | $566,354,000.00 | ★ $4,770,600,000.00 |
| Revenue This Year | $38.84 | $13.22 |
| Revenue Next Year | $20.43 | $1.67 |
| P/E Ratio | $53.83 | ★ N/A |
| Revenue Growth | 41.20 | ★ 170.50 |
| 52 Week Low | $55.00 | $9.15 |
| 52 Week High | $156.00 | $14.38 |
Technical Indicators
Market Signals| Indicator | TMDX | LBTYB |
|---|---|---|
| Relative Strength Index (RSI) | 54.31 | 47.61 |
| Support Level | $133.50 | $11.11 |
| Resistance Level | $156.00 | $11.92 |
| Average True Range (ATR) | 8.50 | 0.19 |
| MACD | 0.41 | -0.02 |
| Stochastic Oscillator | 55.98 | 28.75 |
Price Performance
Historical ComparisonAbout TMDX TransMedics Group Inc.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.
About LBTYB Liberty Global Ltd. Class B
Liberty Global is a holding company with interests in European telecom companies in the UK, the Netherlands, Belgium, Ireland, and Slovakia. Liberty owns the main cable network in each of these geographies and has pursued a strategy since 2016 to merge or partner with mobile network operators to be able to offer converged services. Liberty also owns minority stakes in other media, entertainment, and cloud companies.